Organization (Academic)
Ball State University
ClinicalTrials.gov lists Ball State University as lead sponsor of 12 trials. It has 7 active development programs and 1 approved asset.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Ball State University: 12 lead-sponsored trials and 2 legal-entity registrations.
Disease areas (10)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Obesity | 3 |
| Autism Spectrum Disorder | 2 |
| Autistic Disorder | 2 |
| Inflammation | 2 |
| Obesity, Metabolically Benign | 2 |
Showing 5 of 10 disease areas.
Trials by start year as sponsor or collaborator (8)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 2 |
| 2018 | 2 |
| 2017 | 1 |
| 2001 | 1 |
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (7)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Maltodextrin | Obesity, Metabolically Benign | Not reported | 1 |
| Maltodextrin | Obesity | Not reported | 1 |
| Inulin | Obesity, Metabolically Benign | Not reported | 1 |
| Inulin | Inflammation | Not reported | 1 |
| Inulin | Insulin Resistance | Not reported | 1 |
Showing 5 of 7 active programs.
Approved assets (1)
| Drug | Trials |
|---|---|
| Inulin | 1 |
Journals published in (10)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| American journal of kidney diseases : the official journal of the National Kidney Foundation | 1 |
| Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme | 1 |
| Blood purification | 1 |
| Clinical nutrition (Edinburgh, Scotland) | 1 |
| International urology and nephrology | 1 |
Showing 5 of 10 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 7 | 1 | 2022-02-08 |
Financing and grant events (19)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2025-09-16 | NIH grant | 549,460 | Reporter |
| 2025-07-23 | NIH grant | 560,460 | Reporter |
| 2024-08-20 | NIH grant | 1,100,000 | Reporter |
| 2024-08-08 | NIH grant | 475,516 | Reporter |
| 2024-07-31 | NIH grant | 447,337 | Reporter |
Showing 5 of 19 events.
Organization relationships (6)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Indiana University | Co sponsors trial with | 2 |
| University of Louisville | Co sponsors trial with | 1 |
| Government of the United States of America | Co sponsors trial with | 1 |
| University System of Ohio | Co sponsors trial with | 1 |
| University of Nebraska | Co sponsors trial with | 1 |
Showing 5 of 6 relationships.
Latest dated events (41)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-03-21 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-03-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-02-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-16 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-07-23 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
Showing 5 of 41 events.
Biomarkers this organization publishes on (64)
Shown in this order: most publications first.
Showing 5 of 64 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.